The Next 2 Obesity Drug Stocks? Plus, Bitcoin’s Bounce

Barron's Streetwise - A podcast by Barron's - Fridays

Categories:

Business

A top biotech analyst looks beyond Eli Lilly and Novo Nordisk for weight loss investments. Jack talks stocks, bonds, rates, and crypto. Learn more about your ad choices. Visit megaphone.fm/adchoices